INCR logo

InterCure Ltd. (INCR)

Profile

Full Name

InterCure Ltd.

Ticker

NASDAQ: INCR

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

Israel

IPO

January 28, 2019

Indexes

Not included

Website

http://www.intercure.co

Employees

320

Key Details

Price

$1.55(+0.65%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$64.59M(-33.15% YoY)

Annual EPS

-$0.40(-8.28% YoY)

PE ratio

-

Next earnings date

Aug 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.55
    INCR price is $1.55

    30-Day Relative Volume

    0.98
    INCR 30-day relative volume is 0.98

    Price Performance

    Price Most recent change

    +0.65%
    INCR price was up +0.65% on Jul 25, 2025

    Price YTD change

    -2.52%
    INCR price is down -2.52% since January 1st

    Price 1-year change

    -35.68%
    INCR price is down -35.68% year-on-year

    Price 3-year change

    -74.71%
    INCR price is down -74.71% over the past 3 years

    Price Range

    Price All-time high

    $9.99
    INCR price is currently -84.48% below its historical high of $9.99

    Price 3-year low

    $0.99
    INCR price is currently +56.57% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $84.49M
    INCR market capitalization is $84.49 million

    Market cap 3-year change

    -69.46%
    INCR market capitalization is down -69.46% over the past 3 years

    Market cap All-time high

    $370.10M
    INCR market capitalization is currently -77.17% below its historical high of $370.10 million

    Market cap sector rank

    40.31%
    INCR market capitalization is higher than 40.31% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +19.62%
    INCR shares outstanding is up +19.62% year-on-year

    Shares Outstanding 3-Year Change

    +20.78%
    INCR shares outstanding is up +20.78% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.41
    INCR beta is 0.41

    200-day SMA

    $1.55
    INCR price is currently +0.16% above its 200-day simple moving average

    50-day SMA

    $1.53
    INCR price is currently +1.39% above its 50-day simple moving average

    RSI

    52.89
    INCR 14-day relative strength index is 52.89

    Volume

    0.98
    INCR 30-day relative volume is 0.98

    ATR

    $0.06
    INCR average true range is $0.06

    10-day Historical Volatility

    30.66%
    INCR 10-day historical volatility is 30.66%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $64.59M
    INCR annual revenue is $64.59 million

    Revenue Analysts estimate

    -
    INCR annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -33.15%
    INCR annual revenue is down -33.15% year-on-year

    Revenue Sector rank

    50.74%
    INCR annual revenue is higher than 50.74% of companies in Healthcare sector

    EPS

    EPS

    -$0.40
    INCR annual earnings per share is -$0.40

    EPS Analysts estimate

    -
    INCR annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -8.28%
    INCR annual earnings per share is down -8.28% year-on-year

    EPS Sector rank

    69.63%
    INCR annual earnings per share is higher than 69.63% of companies in Healthcare sector

    Profit

    Gross profit

    $8.18M
    INCR annual gross profit is $8.18 million

    Gross margin

    12.66%
    INCR annual gross profit margin is 12.66%

    Operating profit

    -$12.18M
    INCR annual operating income is -$12.18 million

    Operating margin

    -18.86%
    INCR annual operating profit margin is -18.86%

    Net income

    -$18.33M
    INCR annual net profit is -$18.33 million

    Net margin

    -28.38%
    INCR annual net profit margin is -28.38%

    Expenses

    Total expenses

    $76.77M
    INCR annual total expenses is $76.77 million

    Operating expenses

    $20.36M
    INCR annual total operating expenses is $20.36 million

    Cost of goods sold

    $56.41M
    INCR annual cost of goods sold is $56.41 million

    Selling, general & administrative expenses

    $22.89M
    INCR annual SGA is $22.89 million

    Depreciation and amortization

    $4.16M
    INCR annual depreciation & amortization is $4.16 million

    Interest expense

    $5.58M
    INCR annual interest expense is $5.58 million

    Income tax

    -$3.93M
    INCR annual income tax is -$3.93 million

    EBIT & EBITDA

    EBIT

    -$18.03M
    INCR annual earnings before interest & taxes is -$18.03 million

    EBITDA

    -$13.87M
    INCR annual EBITDA is -$13.87 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $208.75M
    INCR annual total assets is $208.75 million

    Non current assets

    $101.49M
    INCR annual long term assets is $101.49 million

    Current assets

    $107.25M
    INCR annual total current assets is $107.25 million

    Cash and cash equivalents

    $21.44M
    INCR annual cash & cash equivalents is $21.44 million

    Accounts receivable

    $14.19M
    INCR annual accounts receivable is $14.19 million

    Inventory

    $34.31M
    INCR annual inventory is $34.31 million

    Liabilities

    Total liabilities

    $99.89M
    INCR annual total liabilities is $99.89 million

    Long term liabilities

    $37.82M
    INCR annual total long term liabilities is $37.82 million

    Current liabilities

    $62.07M
    INCR annual total current liabilities is $62.07 million

    Accounts payable

    $21.23M
    INCR annual accounts payable is $21.23 million

    Debt

    Total debt

    $57.87M
    INCR annual total debt is $57.87 million

    Total debt 1-year change

    +6.4%
    INCR annual total debt is up +6.4% year-on-year

    Long term debt

    $37.55M
    INCR annual long term debt is $37.55 million

    Short term debt

    $20.32M
    INCR annual short term debt is $20.32 million

    Equity & Capital

    Shareholders equity

    $108.67M
    INCR annual stockholders equity is $108.67 million

    Book value

    $108.67M
    INCR annual book value is $108.67 million

    Retained earnings

    -$75.98M
    INCR annual retained earnings is -$75.98 million

    Working capital

    $45.18M
    INCR annual working capital is $45.18 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$18.10M
    INCR annual cash flow from operations is -$18.10 million

    Cash from operations 1-year change

    -24.18%
    INCR annual cash flow from operations is down -24.18% year-on-year

    Cash from investing

    $4.78M
    INCR annual cash flow from investing activities is $4.78 million

    Cash from investing 1-year change

    +268.8%
    INCR annual cash flow from investing activities is up +268.8% year-on-year

    Cash from financing

    $7.15M
    INCR annual cash flow from financing activities is $7.15 million

    Cash from financing 1-year change

    +131.76%
    INCR annual cash flow from financing activities is up +131.76% year-on-year

    CAPEX

    CAPEX

    $1.18M
    INCR annual capital expenditures is $1.18 million

    CAPEX 1-year change

    +66.26%
    INCR annual capital expenditures is up +66.26% year-on-year

    Free Cash Flow

    Free cash flow

    -$19.28M
    INCR annual free cash flow is -$19.28 million

    Free cash flow 1-year change

    -26.14%
    INCR annual free cash flow is down -26.14% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    12.66%
    INCR annual gross profit margin is 12.66%

    Operating margin

    -18.86%
    INCR annual operating profit margin is -18.86%

    Net margin

    -28.38%
    INCR annual net profit margin is -28.38%

    ROA & ROE

    ROA

    -8.58%
    INCR annual return on assets is -8.58%

    ROE

    -15.54%
    INCR annual return on equity is -15.54%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    INCR price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    INCR price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.78
    INCR price to book ratio is 0.78

    PB ratio Sector rank

    32.26%
    INCR price to book ratio is higher than 32.26% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    INCR price to sales ratio value is unknown

    PS ratio Sector rank

    -
    INCR price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $120.93M
    INCR enterprise value is $120.93 million

    Enterprise value Sector rank

    46.46%
    INCR enterprise value is higher than 46.46% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    INCR EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    INCR EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.73
    INCR annual current ratio is 1.73

    Quick ratio

    1.18
    INCR annual quick ratio is 1.18

    Leverage

    Debt to equity

    0.46
    INCR annual debt to equity ratio is 0.46

    Interest coverage ratio

    -3.23
    INCR annual interest coverage ratio is -3.23

    Risk & Stability

    Piotroski F-Score

    -
    INCR piotroski f-score value is unknown

    Altman Z-Score

    0.28
    INCR altman z-score is 0.28

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with INCR included

    Growing Shares Outstanding
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Ex Dividend dates calendar
    Small cap stocks
    Israeli stocks
    Stocks with low beta
    • What is the ticker symbol for InterCure Ltd.?
    • Does InterCure Ltd. pay dividends?
    • What sector is InterCure Ltd. in?
    • What industry is InterCure Ltd. in?
    • What country is InterCure Ltd. based in?
    • When did InterCure Ltd. go public?
    • Is InterCure Ltd. in the S&P 500?
    • Is InterCure Ltd. in the NASDAQ 100?
    • Is InterCure Ltd. in the Dow Jones?
    • When was InterCure Ltd.'s last earnings report?
    • When does InterCure Ltd. report earnings?

    What is the ticker symbol for InterCure Ltd.?

    The ticker symbol for InterCure Ltd. is NASDAQ:INCR

    Does InterCure Ltd. pay dividends?

    No, InterCure Ltd. does not pay dividends

    What sector is InterCure Ltd. in?

    InterCure Ltd. is in the Healthcare sector

    What industry is InterCure Ltd. in?

    InterCure Ltd. is in the Specialty & Generic Drug Manufacturers industry

    What country is InterCure Ltd. based in?

    InterCure Ltd. is headquartered in Israel

    When did InterCure Ltd. go public?

    InterCure Ltd.'s initial public offering (IPO) was on January 28, 2019

    Is InterCure Ltd. in the S&P 500?

    No, InterCure Ltd. is not included in the S&P 500 index

    Is InterCure Ltd. in the NASDAQ 100?

    No, InterCure Ltd. is not included in the NASDAQ 100 index

    Is InterCure Ltd. in the Dow Jones?

    No, InterCure Ltd. is not included in the Dow Jones index

    When was InterCure Ltd.'s last earnings report?

    InterCure Ltd.'s most recent earnings report was on May 1, 2025

    When does InterCure Ltd. report earnings?

    The next expected earnings date for InterCure Ltd. is August 29, 2025
    On this page